Nowak P, Martínez F, Sørensen M. "一种的合成方法" [P]. European Patent, EP 3724432 A1, 2025-10-16.
发明人郭海燕,唐晓军,王建平. "Method for the Synthesis of 5-{[(2-fluorophenyl)methyl]amino}-2,3-dihydro-1h-1,3-benzodiazol-2-one" [P]. 中国发明专利, 专利号 CN 111730167 B, 授权公告日 2020-05-07.
发明人孙丽萍,唐晓军,杨光. "A Process for Preparing High-Purity 5-{[(2-fluorophenyl)methyl]amino}-2,3-dihydro-1h-1,3-benzodiazol-2-one" [P]. 中国发明专利, 专利号 CN 113642045 A, 授权公告日 2017-10-24.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2018, 963, 8012-8018.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2013, 792, 1313-1343.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 5-{[(2-fluorophenyl)methyl]amino}-2,3-dihydro-1h-1,3-benzodiazol-2-one Using HRMS and NMR". Phytochemistry, 2015, 222, 6254-6259.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2012, 474, 1401-1406.